(MBLY) Mobileye Global Common Stock - Overview
Exchange: NASDAQ •
Country: Israel •
Currency: USD •
Type: Common Stock •
ISIN: US60741F1049
Stock: Driver Assistance, Autonomous Driving, Sensing Systems, Software
Total Rating 9
Risk 26
Buy Signal -1.68
| Risk 5d forecast | |
|---|---|
| Volatility | 59.6% |
| Relative Tail Risk | -6.70% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.96 |
| Alpha | -83.86 |
| Character TTM | |
|---|---|
| Beta | 1.985 |
| Beta Downside | 2.910 |
| Drawdowns 3y | |
|---|---|
| Max DD | 83.66% |
| CAGR/Max DD | -0.52 |
EPS (Earnings per Share)
Revenue
Description: MBLY Mobileye Global Common Stock March 05, 2026
Mobileye Global Inc. (NASDAQ: MBLY) develops advanced driver assistance systems (ADAS) and autonomous driving technologies globally. The company operates in two segments: Mobileye and Moovit.
Mobileye offers a range of ADAS and autonomous driving solutions. These include Base ADAS for basic safety features, Cloud-Enhanced ADAS utilizing crowdsourced data for improved localization and driving experience, and Mobileye Surround ADAS for hands-off highway driving with features like automatic lane change and collision avoidance. The automotive technology sector is characterized by rapid innovation in sensor technology and AI algorithms.
Further offerings include Mobileye SuperVision for hands-off driver assistance, Mobileye Chauffeur for hands-off consumer vehicles, and Mobileye Drive for fleet-focused self-driving systems for robotaxis and public transport. Their core technology involves EyeQ System-on-Chip (SoC) for basic safety features and True Redundancy AI architecture. The business model involves supplying solutions to original equipment manufacturers (OEMs) and fleet operators.
Founded in 1999 and headquartered in Jerusalem, Israel, Mobileye is a subsidiary of Intel Corporation. To understand MBLYs market position and financial health, further research on platforms like ValueRay is recommended.
Headlines to watch out for
- Automaker adoption of ADAS and autonomous driving systems
- Regulatory mandates for ADAS features increase demand
- Competition from other ADAS and autonomous driving developers
- Supply chain disruptions impact EyeQ chip production
- Global vehicle production volumes affect Mobileye revenue
Piotroski VR‑10 (Strict, 0-10) 4.0
| Net Income: -392.0m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.04 > 0.02 and ΔFCF/TA 1.72 > 1.0 |
| NWC/Revenue: 109.4% < 20% (prev 111.3%; Δ -1.91% < -1%) |
| CFO/TA 0.05 > 3% & CFO 613.2m > Net Income -392.0m |
| Net Debt (-1.84b) to EBITDA (122.0m): -15.05 < 3 |
| Current Ratio: 6.10 > 1.5 & < 3 |
| Outstanding Shares: last quarter (814.0m) vs 12m ago 0.62% < -2% |
| Gross Margin: 47.73% > 18% (prev 0.45%; Δ 4.73k% > 0.5%) |
| Asset Turnover: 15.11% > 50% (prev 13.15%; Δ 1.96% > 0%) |
| Interest Coverage Ratio: -21.94 > 6 (EBITDA TTM 122.0m / Interest Expense TTM -18.0m) |
Altman Z'' -5.91
| A: 0.17 (Total Current Assets 2.48b - Total Current Liabilities 406.0m) / Total Assets 12.49b |
| B: -0.28 (Retained Earnings -3.45b / Total Assets 12.49b) |
| C: -0.03 (EBIT TTM -395.0m / Avg Total Assets 12.54b) |
| D: -5.61 (Book Value of Equity -3.43b / Total Liabilities 611.0m) |
| Altman-Z'' Score: -5.91 = D |
Beneish M -3.46
| DSRI: 0.54 (Receivables 131.0m/212.0m, Revenue 1.89b/1.65b) |
| GMI: 0.94 (GM 47.73% / 44.80%) |
| AQI: 0.97 (AQ_t 0.76 / AQ_t-1 0.79) |
| SGI: 1.15 (Revenue 1.89b / 1.65b) |
| TATA: -0.08 (NI -392.0m - CFO 613.2m) / TA 12.49b) |
| Beneish M-Score: -3.46 (Cap -4..+1) = AA |
What is the price of MBLY shares?
As of March 19, 2026, the stock is trading at USD 7.93 with a total of 3,732,780 shares traded.
Over the past week, the price has changed by +0.38%, over one month by -14.55%, over three months by -21.56% and over the past year by -46.99%.
Over the past week, the price has changed by +0.38%, over one month by -14.55%, over three months by -21.56% and over the past year by -46.99%.
Is MBLY a buy, sell or hold?
Mobileye Global Common Stock has received a consensus analysts rating of 3.89.
Therefore, it is recommended to buy MBLY.
- StrongBuy: 12
- Buy: 2
- Hold: 13
- Sell: 1
- StrongSell: 0
What are the forecasts/targets for the MBLY price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 15.6 | 96.2% |
| Analysts Target Price | 15.6 | 96.2% |
MBLY Fundamental Data Overview March 16, 2026
P/E Forward = 23.6407
P/S = 3.3629
P/B = 0.5361
P/EG = 0.3943
Revenue TTM = 1.89b USD
EBIT TTM = -395.0m USD
EBITDA TTM = 122.0m USD
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = 67.0m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -1.84b USD (from netDebt column, last quarter)
Enterprise Value = 4.60b USD (6.37b + Debt 67.0m - CCE 1.84b)
Interest Coverage Ratio = -21.94 (Ebit TTM -395.0m / Interest Expense TTM -18.0m)
EV/FCF = 8.64x (Enterprise Value 4.60b / FCF TTM 532.2m)
FCF Yield = 11.57% (FCF TTM 532.2m / Enterprise Value 4.60b)
FCF Margin = 28.10% (FCF TTM 532.2m / Revenue TTM 1.89b)
Net Margin = -20.70% (Net Income TTM -392.0m / Revenue TTM 1.89b)
Gross Margin = 47.73% ((Revenue TTM 1.89b - Cost of Revenue TTM 990.0m) / Revenue TTM)
Gross Margin QoQ = 45.29% (prev 48.21%)
Tobins Q-Ratio = 0.37 (Enterprise Value 4.60b / Total Assets 12.49b)
Interest Expense / Debt = 11.94% (Interest Expense 8.00m / Debt 67.0m)
Taxrate = 21.0% (US default 21%)
NOPAT = -312.1m (EBIT -395.0m * (1 - 21.00%)) [loss with tax shield]
Current Ratio = 6.10 (Total Current Assets 2.48b / Total Current Liabilities 406.0m)
Debt / Equity = 0.01 (Debt 67.0m / totalStockholderEquity, last quarter 11.88b)
Debt / EBITDA = -15.05 (Net Debt -1.84b / EBITDA 122.0m)
Debt / FCF = -3.45 (Net Debt -1.84b / FCF TTM 532.2m)
Total Stockholder Equity = 11.98b (last 4 quarters mean from totalStockholderEquity)
RoA = -3.13% (Net Income -392.0m / Total Assets 12.49b)
RoE = -3.27% (Net Income TTM -392.0m / Total Stockholder Equity 11.98b)
RoCE = -3.27% (EBIT -395.0m / Capital Employed (Total Assets 12.49b - Current Liab 406.0m))
RoIC = -2.60% (negative operating profit) (NOPAT -312.1m / Invested Capital 11.98b)
WACC = 13.19% (E(6.37b)/V(6.44b) * Re(13.23%) + D(67.0m)/V(6.44b) * Rd(11.94%) * (1-Tc(0.21)))
Discount Rate = 13.23% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 0.49%
[DCF] Terminal Value 62.09% ; FCFF base≈446.9m ; Y1≈459.8m ; Y5≈515.5m
[DCF] Fair Price = 25.88 (EV 4.47b - Net Debt -1.84b = Equity 6.30b / Shares 243.6m; r=13.19% [WACC]; 5y FCF grow 2.89% → 2.90% )
EPS Correlation: -48.25 | EPS CAGR: -24.57% | SUE: -4.0 | # QB: 0
Revenue Correlation: 4.31 | Revenue CAGR: 3.36% | SUE: 0.53 | # QB: 0
EPS next Quarter (2026-06-30): EPS=0.06 | Chg7d=+0.000 | Chg30d=-0.037 | Revisions Net=-11 | Analysts=19
EPS current Year (2026-12-31): EPS=0.25 | Chg7d=-0.002 | Chg30d=+0.000 | Revisions Net=+0 | Growth EPS=-27.5% | Growth Revenue=+3.0%
EPS next Year (2027-12-31): EPS=0.38 | Chg7d=-0.001 | Chg30d=+0.001 | Revisions Net=+0 | Growth EPS=+50.3% | Growth Revenue=+15.3%
[Analyst] Revisions Ratio: -1.00 (0 Up / 11 Down within 30d for Next Quarter)
P/S = 3.3629
P/B = 0.5361
P/EG = 0.3943
Revenue TTM = 1.89b USD
EBIT TTM = -395.0m USD
EBITDA TTM = 122.0m USD
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = 67.0m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -1.84b USD (from netDebt column, last quarter)
Enterprise Value = 4.60b USD (6.37b + Debt 67.0m - CCE 1.84b)
Interest Coverage Ratio = -21.94 (Ebit TTM -395.0m / Interest Expense TTM -18.0m)
EV/FCF = 8.64x (Enterprise Value 4.60b / FCF TTM 532.2m)
FCF Yield = 11.57% (FCF TTM 532.2m / Enterprise Value 4.60b)
FCF Margin = 28.10% (FCF TTM 532.2m / Revenue TTM 1.89b)
Net Margin = -20.70% (Net Income TTM -392.0m / Revenue TTM 1.89b)
Gross Margin = 47.73% ((Revenue TTM 1.89b - Cost of Revenue TTM 990.0m) / Revenue TTM)
Gross Margin QoQ = 45.29% (prev 48.21%)
Tobins Q-Ratio = 0.37 (Enterprise Value 4.60b / Total Assets 12.49b)
Interest Expense / Debt = 11.94% (Interest Expense 8.00m / Debt 67.0m)
Taxrate = 21.0% (US default 21%)
NOPAT = -312.1m (EBIT -395.0m * (1 - 21.00%)) [loss with tax shield]
Current Ratio = 6.10 (Total Current Assets 2.48b / Total Current Liabilities 406.0m)
Debt / Equity = 0.01 (Debt 67.0m / totalStockholderEquity, last quarter 11.88b)
Debt / EBITDA = -15.05 (Net Debt -1.84b / EBITDA 122.0m)
Debt / FCF = -3.45 (Net Debt -1.84b / FCF TTM 532.2m)
Total Stockholder Equity = 11.98b (last 4 quarters mean from totalStockholderEquity)
RoA = -3.13% (Net Income -392.0m / Total Assets 12.49b)
RoE = -3.27% (Net Income TTM -392.0m / Total Stockholder Equity 11.98b)
RoCE = -3.27% (EBIT -395.0m / Capital Employed (Total Assets 12.49b - Current Liab 406.0m))
RoIC = -2.60% (negative operating profit) (NOPAT -312.1m / Invested Capital 11.98b)
WACC = 13.19% (E(6.37b)/V(6.44b) * Re(13.23%) + D(67.0m)/V(6.44b) * Rd(11.94%) * (1-Tc(0.21)))
Discount Rate = 13.23% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 0.49%
[DCF] Terminal Value 62.09% ; FCFF base≈446.9m ; Y1≈459.8m ; Y5≈515.5m
[DCF] Fair Price = 25.88 (EV 4.47b - Net Debt -1.84b = Equity 6.30b / Shares 243.6m; r=13.19% [WACC]; 5y FCF grow 2.89% → 2.90% )
EPS Correlation: -48.25 | EPS CAGR: -24.57% | SUE: -4.0 | # QB: 0
Revenue Correlation: 4.31 | Revenue CAGR: 3.36% | SUE: 0.53 | # QB: 0
EPS next Quarter (2026-06-30): EPS=0.06 | Chg7d=+0.000 | Chg30d=-0.037 | Revisions Net=-11 | Analysts=19
EPS current Year (2026-12-31): EPS=0.25 | Chg7d=-0.002 | Chg30d=+0.000 | Revisions Net=+0 | Growth EPS=-27.5% | Growth Revenue=+3.0%
EPS next Year (2027-12-31): EPS=0.38 | Chg7d=-0.001 | Chg30d=+0.001 | Revisions Net=+0 | Growth EPS=+50.3% | Growth Revenue=+15.3%
[Analyst] Revisions Ratio: -1.00 (0 Up / 11 Down within 30d for Next Quarter)